Leerink Partnrs Estimates Zymeworks’ Q1 Earnings (NYSE:ZYME)
Zymeworks Inc. (NYSE:ZYME – Free Report) – Analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Zymeworks in a research note issued to investors on Tuesday, March 18th. Leerink Partnrs analyst A. Berens expects that the company will earn ($0.51) per share for the quarter. The consensus estimate for Zymeworks’ current full-year earnings […]
